CXCR3 and cancer: Metagenomics based on stool samples from cancer patients at the time of diagnosis reveals a correlation between clinical response to immune checkpoint inhibitors and the relative abundance of A. muciniphila recruitment of CCR9 + CXCR3 + CD4 + T lymphocytes into the mouse tumor bed (Routy et al., 2018).